Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic CancerSusan Tsai, Douglas B. Evans, Chad A. Barnes et al.|Annals of Surgery|2018Cited by 237
Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgeryChad A. Barnes, Kathleen K. Christians, Susan Tsai et al.|Surgery|2019Cited by 63
Locally advanced pancreas cancer: Staging and goals of therapyN. Chatzizacharias, Kathleen K. Christians, Susan Tsai et al.|Surgery|2018Cited by 58
Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic CancerD. Wittmann, Susan Tsai, William A. Hall et al.|Frontiers in Oncology|2020Cited by 35
Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy?Chad A. Barnes, Susan Tsai, Ashley N. Krepline et al.|Journal of Gastrointestinal Surgery|2017Cited by 32